Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022
22 févr. 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
11 janv. 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary revenue...
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
28 déc. 2021 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present...
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
21 déc. 2021 09h25 HE
|
Bioventus, Inc.
DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of...
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
20 déc. 2021 08h30 HE
|
Bioventus, Inc.
DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and Drug...
Bioventus to Expand Operations and Manufacturing in Memphis
18 nov. 2021 08h45 HE
|
Bioventus, Inc.
MEMPHIS, Tenn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has signed a lease agreement to...
Bioventus Announces Chief Financial Officer Transition Plan
15 nov. 2021 07h30 HE
|
Bioventus, Inc.
DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today announced that Greg Anglum is...
Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
09 nov. 2021 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
01 nov. 2021 08h30 HE
|
Bioventus, Inc.
DURHAM, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Sharon Klugewicz as...
Bioventus Completes the Acquisition of Misonix
29 oct. 2021 08h25 HE
|
Bioventus, Inc.
DURHAM, N.C., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed the acquisition of...